Relative cost of etanercept versus infliximab in the treatment of rheumatoid arthritis.

被引：0
作者：
Sweis, BP
Ellman, CJ
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Univ Jordan, Amman, Jordan
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
[41]   Etanercept for the treatment of rheumatoid arthritis [J].
Zhao, Sizheng ;
Mysler, Eduardo ;
Moots, Robert J. .
IMMUNOTHERAPY, 2018, 10 (06) :433-445
[42]   Etanercept for the treatment of rheumatoid arthritis [J].
Lethaby, Anne ;
Lopez-Olivo, Maria Angeles ;
Maxwell, Lara ;
Burls, Amanda ;
Tugwell, Peter ;
Wells, George A. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (05)
[43]   Treatment of rheumatoid arthritis with etanercept [J].
Genovese, MC ;
Kremer, JM .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2004, 30 (02) :311-+
[44]   Etanercept in the treatment of rheumatoid arthritis [J].
Hunt, Laura ;
Emery, Paul .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (10) :1441-1450
[45]   A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness [J].
Chen, Y-F ;
Jobanputra, P. ;
Barton, P. ;
Jowett, S. ;
Bryan, S. ;
Clark, W. ;
Fry-Smith, A. ;
Burls, A. .
HEALTH TECHNOLOGY ASSESSMENT, 2006, 10 (42) :1-+
[46]   Impact of treatment with infliximab on anticyclic citrullinated peptide antibody and rheumatoid factor in patients with rheumatoid arthritis. [J].
Mubashir, E ;
Ahmed, MM ;
Wolf, RE ;
Hayat, S ;
Hall, VC ;
Shi, R ;
Berney, SM .
JOURNAL OF INVESTIGATIVE MEDICINE, 2006, 54 (01) :S284-S284
[47]   A threshold cost-effectiveness comparison of infliximab and etanercept in adults with rheumatoid arthritis in the UK. [J].
Bansback, N ;
Brennan, A ;
Conway, P ;
Reynolds, AV .
ARTHRITIS AND RHEUMATISM, 2002, 46 (09) :S582-S582
[48]   Combination treatment with infliximab and methotrexate or leflunomide in active rheumatoid arthritis. Safety and efficacy [J].
Athanassiou, P ;
Kostoglou-Athanassiou, I ;
Koutsogeorgopoulou, L ;
Galanaki, C ;
Kordalis, A ;
Konstantopoulou, R ;
Sarlanis, T ;
Vezyroglou, G .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 :464-464
[49]   Cost-effectiveness of anakinra plus methotrexate versus methotrexate alone for the treatment of rheumatoid arthritis. [J].
Guh, DP ;
Marra, CA ;
Woolcott, JC ;
Gignac, M ;
Esdaile, JM ;
Clarke, A ;
Anis, AH .
ARTHRITIS AND RHEUMATISM, 2003, 48 (09) :S264-S264
[50]   Comparison of the cost-efficacy of biologics in the treatment of rheumatoid arthritis. [J].
Chiou, CF ;
Wanke, LA ;
Reyes, C ;
Malone, DC ;
Ortmeier, BG ;
Ofman, JJ ;
Weisman, M .
ARTHRITIS AND RHEUMATISM, 2003, 48 (09) :S263-S263
12345